Janaki Deepak on Muck Rack

Janaki Deepak

As seen in: Frontiers, medRxiv, Baltimore Times
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Janaki

Contact Janaki, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Differential Non-Coding RNA Profiles for Lung Cancer Early Detection in African and White Americans

|
By Lu Gao, Pushpa Dhilipkannah, Janaki Deepak, van Holden
| medRxiv
The authors have declared no competing interest. https://www.medschool.umaryland.edu/profiles/jiang-feng/ NCI I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study received approval from the Institutional Review Board of the University of Maryland Baltimore.
Open in Who Shared View Duplicates (20) Issue with article?

Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review

|
By Qin Chen, Petros Christopoulos, Janaki Deepak, Giulio Rossi
| Frontiers
Highlights 1. EML4-ALK+ Neuroendocrine lung cancer treated with ALK-TKI inhibitors showed a rapid response; 2. Large cell Neuroendocrine cancer patients with ALK fusion are mostly nonsmoking, young, and female; 3. Routine ALK IHC is recommended in advanced large-cell neuroendocrine cancer patients.
Open in Who Shared Issue with article?

Lung cancer screening beliefs in Armenia

|
By Kristopher Attwood, Janaki Deepak, Umamaheswaran Gurusamy, Hajo Zeeb
| Frontiers
Introduction Lung cancer is the second most common cancer globally (1) and almost two-thirds of lung cancer deaths occur in low and middle-income countries (LMICs) (2). Within this cohort, upper-middle income countries have the highest rates of lung cancer incidence and mortality (2). Armenia, an upper-middle income country of 3 million in the South Caucasus (3), has more than twice the global age-standardized incidence of lung cancer (4, 5) and the magnitude is only increasing (6).
Open in Who Shared Issue with article?
See all 7 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified